Expression of Ki-67 and COX-2 in Patients With Upper Urinary Tract Urothelial Carcinoma

Hall, 1998, Prognostic factors, recurrence, and survival in transitional cell carcinoma of the upper urinary tract: a 30-year experience in 252 patients, Urology, 52, 594, 10.1016/S0090-4295(98)00295-7

Catto, 2007, Behavior of urothelial carcinoma with respect to anatomical location, J Urol, 177, 1715, 10.1016/j.juro.2007.01.030

Roupret, 2004, Microsatellite instability as indicator of MSH2 gene mutation in patients with upper urinary tract transitional cell carcinoma, J Med Genet, 41, e91, 10.1136/jmg.2003.017871

Foresman, 1997, Bladder cancer: natural history, tumor markers, and early detection strategies, Semin Surg Oncol, 13, 299, 10.1002/(SICI)1098-2388(199709/10)13:5<299::AID-SSU3>3.0.CO;2-8

Eltz, 2008, Molecular and histological markers in urothelial carcinomas of the upper urinary tract, BJU Int, 102, 532, 10.1111/j.1464-410X.2008.07659.x

Cattoretti, 1992, Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections, J Pathol, 168, 357, 10.1002/path.1711680404

Li, 2004, Ki-67 staining index predicts distant metastasis and survival in locally advanced prostate cancer treated with radiotherapy: an analysis of patients in Radiation Therapy Oncology Group protocol 86-10, Clin Cancer Res, 10, 4118, 10.1158/1078-0432.CCR-1052-03

Morinaga, 2005, Growth index, assessed with Ki-67 and ssDNA labeling; a significant prognosticator for patients undergoing curative resection for hepatocellular carcinoma, J Surg Oncol, 92, 331, 10.1002/jso.20309

Rodriguez-Alonso, 2002, p53 and Ki67 expression as prognostic factors for cancer-related survival in stage T1 transitional cell bladder carcinoma, Eur Urol, 41, 182, 10.1016/S0302-2838(01)00038-0

Okamoto, 2008, Etodolac, a selective cyclooxygenase-2 inhibitor, induces upregulation of E-cadherin and has antitumor effect on human bladder cancer cells in vitro and in vivo, Urology, 71, 156, 10.1016/j.urology.2007.09.061

Shariat, 2003, Correlation of cyclooxygenase-2 expression with molecular markers, pathological features and clinical outcome of transitional cell carcinoma of the bladder, J Urol, 170, 985, 10.1097/01.ju.0000080401.85145.ee

Chatterjee, 2004, Combined effects of p53, p21, and pRb expression in the progression of bladder transitional cell carcinoma, J Clin Oncol, 22, 1007, 10.1200/JCO.2004.05.174

Grossman, 1998, p53 and RB expression predict progression in T1 bladder cancer, Clin Cancer Res, 4, 829

Margulis, 2006, Ki-67 is an independent predictor of bladder cancer outcome in patients treated with radical cystectomy for organ-confined disease, Clin Cancer Res, 12, 7369, 10.1158/1078-0432.CCR-06-1472

Benedict, 1999, Level of retinoblastoma protein expression correlates with p16 (MTS-1/INK4A/CDKN2) status in bladder cancer, Oncogene, 18, 1197, 10.1038/sj.onc.1202452

Koksal, 2006, Reduced E-cadherin and alpha-catenin expressions have no prognostic role in bladder carcinoma, Pathol Oncol Res, 12, 13, 10.1007/BF02893426

Kamijima, 2005, The prognostic value of p53, Ki-67 and matrix metalloproteinases MMP-2 and MMP-9 in transitional cell carcinoma of the renal pelvis and ureter, Int J Urol, 12, 941, 10.1111/j.1442-2042.2005.01159.x

Huben, 1988, Tumor grade and stage as prognostic variables in upper tract urothelial tumors, Cancer, 62, 2016, 10.1002/1097-0142(19881101)62:9<2016::AID-CNCR2820620924>3.0.CO;2-G

Suwa, 1997, Prognostic significance of Ki-67 expression in transitional cell bladder carcinoma after radical cystectomy, Pathol Res Pract, 193, 551, 10.1016/S0344-0338(97)80013-1

Fromont, 2005, Tissue microarray analysis of the prognostic value of E-cadherin, Ki67, p53, p27, survivin and MSH2 expression in upper urinary tract transitional cell carcinoma, Eur Urol, 48, 764, 10.1016/j.eururo.2005.07.005

Kamai, 2000, Prognostic significance of p27Kip1 and Ki-67 expression in carcinoma of the renal pelvis and ureter, BJU Int, 86, 14, 10.1046/j.1464-410x.2000.00726.x

Komhoff, 2000, Enhanced expression of cyclooxygenase-2 in high grade human transitional cell bladder carcinomas, Am J Pathol, 157, 29, 10.1016/S0002-9440(10)64513-0

Mohammed, 1999, Expression of cyclooxygenase-2 (COX-2) in human invasive transitional cell carcinoma (TCC) of the urinary bladder, Cancer Res, 59, 5647

Ristimaki, 2001, Expression of cyclooxygenase-2 in human transitional cell carcinoma of the urinary bladder, Am J Pathol, 158, 849, 10.1016/S0002-9440(10)64033-3

Shirahama, 2001, Relation between cyclooxygenase-2 expression and tumor invasiveness and patient survival in transitional cell carcinoma of the urinary bladder, Cancer, 92, 188, 10.1002/1097-0142(20010701)92:1<188::AID-CNCR1308>3.0.CO;2-W

Miyata, 2005, Expression of cyclooxygenase-2 and EP4 receptor in transitional cell carcinoma of the upper urinary tract, J Urol, 173, 56, 10.1097/01.ju.0000148272.77539.2d

Oku, 2003, Overexpression of cyclooxygenase-2 in high-grade human transitional cell carcinoma of the upper urinary tract, BJU Int, 91, 109, 10.1046/j.1464-410X.2003.03057.x

Nakanishi, 1997, E-cadherin expression in upper-urinary-tract carcinoma, Int J Cancer, 74, 446, 10.1002/(SICI)1097-0215(19970822)74:4<446::AID-IJC15>3.0.CO;2-7

Hitchings, 2004, Prediction of progression in pTa and pT1 bladder carcinomas with p53, p16 and pRb, Br J Cancer, 91, 552, 10.1038/sj.bjc.6601954

Santos, 2003, Expression of cell-cycle regulatory proteins and their prognostic value in superficial low-grade urothelial cell carcinoma of the bladder, Eur J Surg Oncol, 29, 74, 10.1053/ejso.2002.1371